Sandbox/AL: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sildenafil}} | |||
{{ | {{CMG}}; {{AE}} {{PB}} | ||
'''''For patient information, click [[Sildenafil (patient information)|here]]'''''. | |||
{{CMG}}; {{AE}} {{ | |||
'''''For patient information, click | |||
==Overview== | ==Overview== | ||
==Category== | ==Category== | ||
==US Brand Names== | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
[[ | '''| [[Sildenafil indications and usage|Indications and Usage]]''' | ||
'''| [[Sildenafil dosage and administration|Dosage and Administration]]''' | |||
'''| [[Sildenafil dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Sildenafil contraindications|Contraindications]]''' | |||
'''| [[Sildenafil warnings|Warnings]]''' | |||
'''| [[Sildenafil precautions|Precautioins]]''' | |||
'''| [[Sildenafil adverse reactions|Adverse Reactions]]''' | |||
'''| [[Sildenafil drug interactions|Drug Interactions]]''' | |||
'''| [[Sildenafil use in specific populations|Use in Specific Populations]]''' | |||
'''| [[Sildenafil overdosage|Overdosage]]''' | |||
'''| [[Sildenafil description|Description]]''' | |||
'''| [[Sildenafil clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Sildenafil nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[Sildenafil clinical studies|Clinical Studies]]''' | |||
'''| [[Sildenafil how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[Sildenafil patient counseling information|Patient Counseling Information]]''' | |||
'''| [[Sildenafil labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | ==Mechanism of Action== | ||
==References== | ==References== | ||
Line 41: | Line 36: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 15:23, 3 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2] For patient information, click here.
Overview
Category
US Brand Names
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings | Precautioins | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages